Autopsy report · NCT00878657

Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow accrual”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 4 years 6 months before it stopped.
8 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Rutgers, The State University of New Jersey
Sponsor type: University, hospital or other
Conditions: Pancreatic Cancer
Interventions: gemcitabine hydrochloride; intensity-modulated radiation therapy
Participants: 8
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.